Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions
THOUSAND OAKS (dpa-AFX) - The development and distribution of vaccines have been making headlines amid a surge in COVID-19 cases and this past week was no exception.
Novavax Inc. (NVAX), which was up 74%, was one of the top gainers for the week ending January 29, 2021, thanks to encouraging trial results of its COVID-19 vaccine candidate. In a phase III trial, conducted in UK, the two-dose regimen of Novavax vaccine NVX-CoV2373 has been found to have an efficacy rate of 89.3%.
Vaxart Inc. (VXRT), with returns of nearly 68%, was another winner of the week as the company reported new pre-clinical histology data showing that its oral vaccine protected against lung inflammation in hamster models.
70 Stocks Moving In Thursday s Mid-Day Session Benzinga 1/28/2021
Gainers
JanOne Inc. (NYSE: JAN) shares jumped 175.5% to $26.25 amid continued momentum driven by retail investor interest in the stock.
Lianluo Smart Limited (NASDAQ: LLIT) shares surged 133% to $14.54.
AeroCentury Corp. (NYSE: ACY) shares jumped 94.3% to $18.95 after climbing around 18% on Wednesday.
The9 Limited (NASDAQ: NCTY) climbed 62% to $16.62 after declining over 17% on Wednesday. The9 recently signed five legally binding Memorandum of Understanding with five Bitcoin mining machine owners to purchase Bitcoin mining machines by the issuance of Class A ordinary shares.
Sundial Growers Inc. (NASDAQ: SNDL) shares climbed 61.1% to $0.9676 after gaining over 7% on Wednesday.
Newater Technology, Inc. (NASDAQ: NEWA) shares jumped 60% to $5.53.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical .
Conversion Labs, Inc.January 11, 2021 GMT
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo, to the new position of chief medical officer.
ADVERTISEMENT
Dr. Puopolo will be responsible for overseeing the company’s rapidly expanding network of state licensed physicians and ensuring that the company is delivering the highest quality of care. He will also work closely with Conversion Labs’ product and marketing teams to optimize the company’s telemedicine offerings and support expansion into new verticals.
Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer
NEW YORK, Jan. 11, 2021
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist,
Dr. Anthony Puopolo, to the new position of chief medical officer.
Dr. Puopolo will be responsible for overseeing the company’s rapidly expanding network of state licensed physicians and ensuring that the company is delivering the highest quality of care. He will also work closely with Conversion Labs’ product and marketing teams to optimize the company’s telemedicine offerings and support expansion into new verticals.